StonvexLoading…
StonvexStonvexStonvexCore line items from CYN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-08-04 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 | Q1 2025 2025-03-31 | Q3 2024 2024-09-30 |
|---|---|---|---|---|---|
Revenue | $1.11M | $0.00 | $0.00 | $0.00 | $0.00 |
Operating Income | Not available | $-19.13M | $-10.72M | $-5.22M | $-17.29M |
Net Income | Not available | $-17.80M | $-13.04M | $-3.91M | $-17.22M |
EPS (Diluted) | $-0.30 | $-5.20 | $-8.22 | $-3.40 | $-1924.23 |
Total Assets | Not available | $49.27M | $56.18M | $24.35M | $8.48M |
Total Liabilities | Not available | $10.59M | $9.42M | $2.21M | $1.83M |
Cash & Equivalents | Not available | $4.82M | $31.34M | $1.00M | $1.97M |
Free Cash Flow OCF − CapEx | Not available | $-17.71M | $-13.12M | $-6.69M | $-16.29M |
Shares Outstanding | Not available | 7.04M | 7.04M | 1.75M | 2.03M |